Literature DB >> 16272872

Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson's disease.

Puneet Plaha1, Steven S Gill.   

Abstract

Gait disturbance and postural instability are some the most disabling symptoms of idiopathic Parkinson's disease and in late stage disease can be resistant to both medical and surgical therapies. We implanted bilateral deep brain stimulation electrodes into the pedunculopontine nucleus in two patients with advanced Parkinson's disease. We demonstrate for the first time that low frequency (20-25 Hz) stimulation of this nucleus significantly improves gait dysfunction and postural instability in both the 'on' and 'off' medication states. Their combined total Unified Parkinson's Disease Rating Scale score improved by 53% and motor score by 57%. No procedure or stimulation-related complications were observed. If these findings are replicated in a larger number of patients, pedunculopontine nucleus stimulation may provide the means to alleviate these disabling and otherwise treatment-resistant symptoms of advanced Parkinson's disease.

Entities:  

Mesh:

Year:  2005        PMID: 16272872     DOI: 10.1097/01.wnr.0000187637.20771.a0

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  117 in total

1.  Combined pedunculopontine-subthalamic stimulation in Parkinson disease.

Authors:  S Khan; S S Gill; L Mooney; P White; A Whone; D J Brooks; N Pavese
Journal:  Neurology       Date:  2012-03-07       Impact factor: 9.910

Review 2.  The pedunculopontine nucleus as a target for deep brain stimulation.

Authors:  Clement Hamani; Elena Moro; Andres M Lozano
Journal:  J Neural Transm (Vienna)       Date:  2010-12-31       Impact factor: 3.575

3.  Cholinergic and non-cholinergic mesopontine tegmental neurons projecting to the subthalamic nucleus in the rat.

Authors:  Takako Kita; Hitoshi Kita
Journal:  Eur J Neurosci       Date:  2010-12-31       Impact factor: 3.386

Review 4.  Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Authors:  Yoland Smith; Thomas Wichmann; Stewart A Factor; Mahlon R DeLong
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

5.  Understanding the human pedunculopontine nucleus in Parkinson's disease.

Authors:  Anders Fytagoridis; Peter A Silburn; Terry J Coyne; Wesley Thevathasan
Journal:  J Neural Transm (Vienna)       Date:  2016-01-16       Impact factor: 3.575

Review 6.  Role of the pedunculopontine nucleus in controlling gait and sleep in normal and parkinsonian monkeys.

Authors:  C Karachi; Chantal Francois
Journal:  J Neural Transm (Vienna)       Date:  2017-01-13       Impact factor: 3.575

7.  Targeting the brain: considerations in 332 consecutive patients treated by deep brain stimulation (DBS) for severe neurological diseases.

Authors:  Angelo Franzini; Roberto Cordella; Giuseppe Messina; Carlo Efisio Marras; Luigi Michele Romito; Alberto Albanese; Michele Rizzi; Nardo Nardocci; Giovanna Zorzi; Edvin Zekaj; Flavio Villani; Massimo Leone; Orsola Gambini; Giovanni Broggi
Journal:  Neurol Sci       Date:  2012-01-24       Impact factor: 3.307

8.  Temporal-Spatial Profiling of Pedunculopontine Galanin-Cholinergic Neurons in the Lactacystin Rat Model of Parkinson's Disease.

Authors:  Joanna L Elson; Rafael Kochaj; Richard Reynolds; Ilse S Pienaar
Journal:  Neurotox Res       Date:  2017-12-07       Impact factor: 3.911

9.  Improvement of pisa syndrome with contralateral pedunculopontine stimulation.

Authors:  Ludy C Shih; Veronique G Vanderhorst; Andres M Lozano; Clement Hamani; Elena Moro
Journal:  Mov Disord       Date:  2013-02-06       Impact factor: 10.338

10.  The integrative role of the pedunculopontine nucleus in human gait.

Authors:  Brian Lau; Marie-Laure Welter; Hayat Belaid; Sara Fernandez Vidal; Eric Bardinet; David Grabli; Carine Karachi
Journal:  Brain       Date:  2015-03-12       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.